Grant: Doctoral Award: Doctoral Foreign Study Award (DFSA)
Direct Payment
$120,000.00
Immune Responses in Graves' Orbitopathy. An Observational Clinical Research Study
FY 2024-25
Summary
Graves' disease is a common autoimmune disease that causes an overactive thyroid, affecting about 2-3% of people worldwide. A significant portion of those with Graves' (up to 25%) develop thyroid eye disease (TED), a serious inflammatory condition that impacts the tissues around the eyes (eye socket). TED can result in eye discomfort and pain, double vision, bulging eyes (proptosis), permanent facial changes, and in severe cases, blindness. These symptoms can significantly impair physical appearance, worsen quality of life, and negatively impact the economic status of individuals especially during their working years.
Currently, it remains unpredictable which individuals with Graves' disease will develop TED, making early intervention difficult. Although the treatment of TED varies depending on disease severity and activity, therapies have included systemic glucocorticoids, radiation, biological therapies and surgery. The most severe cases often require surgical intervention to reduce symptoms. There is an urgent need for a better understanding of the mechanisms driving TED and the factors that contribute to its progression.
My research employs cutting-edge bioinformatics and computational biology techniques to analyze blood and tissue samples from individuals with Graves' disease-both those with and without TED-as well as healthy controls. By comparing these samples, I aim to identify specific biological markers associated with TED development.
My research has the potential to transform the management of Graves' disease by improving our ability to predict TED in at-risk individuals. By uncovering new biomarkers and pathways, my study could lead to novel treatment strategies, allowing for earlier diagnosis and more personalized approaches to therapy. My study aims to enhance the vision, health, and overall quality of life for those affected by Graves' disease and TED, potentially offering new avenues for prevention and more effective treatment options.
Department
Program
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Recipient
Location
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
516893
Name
Nguyen Anne Xuan-Lan
Country
United Kingdom
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Immune Responses in Graves' Orbitopathy. An Observational Clinical Research Study
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Keyworddelim
Autoimmune Disease; Bioinformatics; Biomarkers; Computational Biology; Genomics; Graves' Disease; Inflammation; Predictive Modeling; Thyroid Eye Disease; Transcriptomics
Abstract
Graves' disease is a common autoimmune disease that causes an overactive thyroid, affecting about 2-3% of people worldwide. A significant portion of those with Graves' (up to 25%) develop thyroid eye disease (TED), a serious inflammatory condition that impacts the tissues around the eyes (eye socket). TED can result in eye discomfort and pain, double vision, bulging eyes (proptosis), permanent facial changes, and in severe cases, blindness. These symptoms can significantly impair physical appearance, worsen quality of life, and negatively impact the economic status of individuals especially during their working years.
Currently, it remains unpredictable which individuals with Graves' disease will develop TED, making early intervention difficult. Although the treatment of TED varies depending on disease severity and activity, therapies have included systemic glucocorticoids, radiation, biological therapies and surgery. The most severe cases often require surgical intervention to reduce symptoms. There is an urgent need for a better understanding of the mechanisms driving TED and the factors that contribute to its progression.
My research employs cutting-edge bioinformatics and computational biology techniques to analyze blood and tissue samples from individuals with Graves' disease-both those with and without TED-as well as healthy controls. By comparing these samples, I aim to identify specific biological markers associated with TED development.
My research has the potential to transform the management of Graves' disease by improving our ability to predict TED in at-risk individuals. By uncovering new biomarkers and pathways, my study could lead to novel treatment strategies, allowing for earlier diagnosis and more personalized approaches to therapy. My study aims to enhance the vision, health, and overall quality of life for those affected by Graves' disease and TED, potentially offering new avenues for prevention and more effective treatment options.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Nguyen, Anne Xuan-Lan
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~